New Results
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate
Meehyun Ko, Sangeun Jeon, Wang-Shick Ryu, Seungtaek Kim
doi: https://doi.org/10.1101/2020.05.12.090035
Meehyun Ko
1Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea
Sangeun Jeon
1Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea
Wang-Shick Ryu
2CEO Office, Institut Pasteur Korea, Seongnam, Korea
Seungtaek Kim
1Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam, Korea
Article usage
Posted May 12, 2020.
Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells: Nafamostat is the most potent antiviral drug candidate
Meehyun Ko, Sangeun Jeon, Wang-Shick Ryu, Seungtaek Kim
bioRxiv 2020.05.12.090035; doi: https://doi.org/10.1101/2020.05.12.090035
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8751)
- Bioinformatics (29195)
- Biophysics (14971)
- Cancer Biology (12095)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14178)
- Epidemiology (2067)
- Evolutionary Biology (18306)
- Genetics (12245)
- Genomics (16801)
- Immunology (11867)
- Microbiology (28083)
- Molecular Biology (11592)
- Neuroscience (60965)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7339)
- Zoology (1651)